Home  »  Hot Stocks   »  We Analyzed the Future Direction of NeuroBo Pharma...

We Analyzed the Future Direction of NeuroBo Pharmaceuticals Inc. (NRBO), Here is What We Found

NeuroBo Pharmaceuticals Inc. (NASDAQ:NRBO) went up by 14.79% from its latest closing price compared to the recent 1-year high of $63.85. The company’s stock price has collected 8.67% of gains in the last five trading sessions.

Is It Worth Investing in NeuroBo Pharmaceuticals Inc. (NASDAQ :NRBO) Right Now?

Plus, the 36-month beta value for NRBO is at -0.15. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for NeuroBo Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


The average price from analysts is $6.00, which is $5.19 above the current price. NRBO currently public float of 6.27M and currently shorts hold a 15.30% ratio of that float. Today, the average trading volume of NRBO was 3.83M shares.

NRBO’s Market Performance

NRBO stocks went up by 8.67% for the week, with a monthly drop of -40.07% and a quarterly performance of -93.24%, while its annual performance rate touched -97.77%. The volatility ratio for the week stands at 8.79% while the volatility levels for the past 30 days are set at 12.93% for NeuroBo Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is -0.36% for NRBO stocks with a simple moving average of -92.88% for the last 200 days.

Analysts’ Opinion of NRBO

Many brokerage firms have already submitted their reports for NRBO stocks, with H.C. Wainwright repeating the rating for NRBO by listing it as a “Buy.” The predicted price for NRBO in the upcoming period, according to H.C. Wainwright is $20 based on the research report published on June 15th of the previous year 2020.

NRBO Trading at -33.03% from the 50-Day Moving Average

After a stumble in the market that brought NRBO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.72% of loss for the given period.

Volatility was left at 12.93%, however, over the last 30 days, the volatility rate increased by 8.79%, as shares sank -34.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -62.27% lower at present.

During the last 5 trading sessions, NRBO rose by +8.67%, which changed the moving average for the period of 200-days by -96.98% in comparison to the 20-day moving average, which settled at $0.7967. In addition, NeuroBo Pharmaceuticals Inc. saw 13.59% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for NRBO

Equity return is now at value -134.30, with -115.80 for asset returns.